These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67. Hepatic tissue engineering on 3-dimensional biodegradable polymers within a pulsatile flow bioreactor. Török E ; Pollok JM; Ma PX; Vogel C; Dandri M; Petersen J; Burda MR; Kaufmann PM; Kluth D; Rogiers X Dig Surg; 2001; 18(3):196-203. PubMed ID: 11464009 [TBL] [Abstract][Full Text] [Related]
68. Preparation and characterization of chitosan-heparin composite matrices for blood contacting tissue engineering. He Q; Ao Q; Gong K; Zhang L; Hu M; Gong Y; Zhang X Biomed Mater; 2010 Oct; 5(5):055001. PubMed ID: 20826908 [TBL] [Abstract][Full Text] [Related]
69. Nano-featured scaffolds for tissue engineering: a review of spinning methodologies. Murugan R; Ramakrishna S Tissue Eng; 2006 Mar; 12(3):435-47. PubMed ID: 16579677 [TBL] [Abstract][Full Text] [Related]
70. Update on the main use of biomaterials and techniques associated with tissue engineering. Steffens D; Braghirolli DI; Maurmann N; Pranke P Drug Discov Today; 2018 Aug; 23(8):1474-1488. PubMed ID: 29608960 [TBL] [Abstract][Full Text] [Related]
71. In vitro and in vivo models for the reconstruction of intercellular signaling. Bouhadir KH; Mooney DJ Ann N Y Acad Sci; 1998 Apr; 842():188-94. PubMed ID: 9599309 [TBL] [Abstract][Full Text] [Related]
72. Transplantation of three-dimensional artificial human vascular tissues fabricated using an extracellular matrix nanofilm-based cell-accumulation technique. Asano Y; Shimoda H; Okano D; Matsusaki M; Akashi M J Tissue Eng Regen Med; 2017 Apr; 11(4):1303-1307. PubMed ID: 26563424 [TBL] [Abstract][Full Text] [Related]
75. Galactose-carrying polymers as extracellular matrices for liver tissue engineering. Cho CS; Seo SJ; Park IK; Kim SH; Kim TH; Hoshiba T; Harada I; Akaike T Biomaterials; 2006 Feb; 27(4):576-85. PubMed ID: 16084586 [TBL] [Abstract][Full Text] [Related]
76. The current status of tissue engineering as potential therapy. Kim SS; Vacanti JP Semin Pediatr Surg; 1999 Aug; 8(3):119-23. PubMed ID: 10461324 [TBL] [Abstract][Full Text] [Related]
77. Cells and materials for liver tissue engineering. Li YS; Harn HJ; Hsieh DK; Wen TC; Subeq YM; Sun LY; Lin SZ; Chiou TW Cell Transplant; 2013; 22(4):685-700. PubMed ID: 23127824 [TBL] [Abstract][Full Text] [Related]
78. In vitro expression of cartilage-specific markers by chondrocytes on a biocompatible hydrogel: implications for engineering cartilage tissue. Risbud M; Ringe J; Bhonde R; Sittinger M Cell Transplant; 2001; 10(8):755-63. PubMed ID: 11814119 [TBL] [Abstract][Full Text] [Related]
79. Three-dimensional cell culture matrices: state of the art. Lee J; Cuddihy MJ; Kotov NA Tissue Eng Part B Rev; 2008 Mar; 14(1):61-86. PubMed ID: 18454635 [TBL] [Abstract][Full Text] [Related]
80. In-vitro engineering of implantable human urinary tract tissue matrices. Danielsson C; Adelöw C; Hubschmid U; Neuenschwander P; Frey P Swiss Med Wkly; 2007 Mar; 137 Suppl 155():93S-98S. PubMed ID: 17874511 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]